HMGB1 and ischemia: Yue, et al. (2018) also published a paper that showed the deactivation of the HMGB1, a pro-inflammatory molecule, in the acute phase of ischemia can lead to suppression of hippocampal inflammatory responses and showed a long-lasting beneficial effects after 2VO (29).